130 related articles for article (PubMed ID: 17433359)
1. In vivo monitoring the fate of Cy5.5-Tat labeled T lymphocytes by quantitative near-infrared fluorescence imaging during acute brain inflammation in a rat model of experimental autoimmune encephalomyelitis.
Berger C; Gremlich HU; Schmidt P; Cannet C; Kneuer R; Hiestand P; Rausch M; Rudin M
J Immunol Methods; 2007 May; 323(1):65-77. PubMed ID: 17433359
[TBL] [Abstract][Full Text] [Related]
2. Lesional accumulation of RhoA(+) cells in brains of experimental autoimmune encephalomyelitis and multiple sclerosis.
Zhang Z; Schittenhelm J; Meyermann R; Schluesener HJ
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):231-40. PubMed ID: 17983427
[TBL] [Abstract][Full Text] [Related]
3. Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulins.
Achiron A; Mor F; Margalit R; Cohen IR; Lider O; Miron S
J Autoimmun; 2000 Nov; 15(3):323-30. PubMed ID: 11040073
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
Li XB; Schluesener HJ
Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain.
Schmied M; Breitschopf H; Gold R; Zischler H; Rothe G; Wekerle H; Lassmann H
Am J Pathol; 1993 Aug; 143(2):446-52. PubMed ID: 8342595
[TBL] [Abstract][Full Text] [Related]
6. Importance of immunoglobulin isotype in therapy of experimental autoimmune encephalomyelitis with monoclonal anti-CD4 antibody.
Waldor MK; Mitchell D; Kipps TJ; Herzenberg LA; Steinman L
J Immunol; 1987 Dec; 139(11):3660-4. PubMed ID: 3500226
[TBL] [Abstract][Full Text] [Related]
7. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis.
Bauer J; Sminia T; Wouterlood FG; Dijkstra CD
J Neurosci Res; 1994 Jul; 38(4):365-75. PubMed ID: 7932870
[TBL] [Abstract][Full Text] [Related]
8. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
[TBL] [Abstract][Full Text] [Related]
9. Semiautomatic landmark-based two-dimensional-three-dimensional image fusion in living mice: correlation of near-infrared fluorescence imaging of Cy5.5-labeled antibodies with flat-panel volume computed tomography.
Dullin C; Zientkowska M; Napp J; Missbach-Guentner J; Krell HW; Müller F; Grabbe E; Tietze LF; Alves F
Mol Imaging; 2009; 8(1):2-14. PubMed ID: 19344571
[TBL] [Abstract][Full Text] [Related]
10. IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier.
Linker RA; Lühder F; Kallen KJ; Lee DH; Engelhardt B; Rose-John S; Gold R
J Neuroimmunol; 2008 Dec; 205(1-2):64-72. PubMed ID: 18950871
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow derived elements and resident microglia in brain inflammation.
Lassmann H; Schmied M; Vass K; Hickey WF
Glia; 1993 Jan; 7(1):19-24. PubMed ID: 7678581
[TBL] [Abstract][Full Text] [Related]
12. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study.
Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G
Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560
[TBL] [Abstract][Full Text] [Related]
13. The use of digital technology to asses the severity of the Experimental Allergic Encephalomyelitis (EAE) spinal cord lesion.
Mohamed A; Tarhuni H; Dufan T; Benghuzzi H; Tucci M
Biomed Sci Instrum; 2004; 40():419-23. PubMed ID: 15133994
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of platelet-derived growth factor by peripheral-blood leukocytes during experimental allergic encephalomyelitis.
Koehler NK; Roebbert M; Dehghani K; Ballmaier M; Claus P; von Hoersten S; Shing M; Odin P; Strehlau J; Heidenreich F
J Neurosci Res; 2008 Feb; 86(2):392-402. PubMed ID: 17893914
[TBL] [Abstract][Full Text] [Related]
15. Methylthioadenosine reverses brain autoimmune disease.
Moreno B; Hevia H; Santamaria M; Sepulcre J; Muñoz J; García-Trevijano ER; Berasain C; Corrales FJ; Avila MA; Villoslada P
Ann Neurol; 2006 Sep; 60(3):323-34. PubMed ID: 16786535
[TBL] [Abstract][Full Text] [Related]
16. C-Phycocyanin ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells.
Pentón-Rol G; Martínez-Sánchez G; Cervantes-Llanos M; Lagumersindez-Denis N; Acosta-Medina EF; Falcón-Cama V; Alonso-Ramírez R; Valenzuela-Silva C; Rodríguez-Jiménez E; Llópiz-Arzuaga A; Marín-Prida J; López-Saura PA; Guillén-Nieto GE; Pentón-Arias E
Int Immunopharmacol; 2011 Jan; 11(1):29-38. PubMed ID: 20971186
[TBL] [Abstract][Full Text] [Related]
17. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
Ellestad KK; Tsutsui S; Noorbakhsh F; Warren KG; Yong VW; Pittman QJ; Power C
J Immunol; 2009 Jul; 183(1):298-309. PubMed ID: 19542441
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE).
Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaei M; Keyvani H
Int Immunopharmacol; 2020 Jan; 78():105943. PubMed ID: 31830622
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of decoy chemokine (7ND) gene therapy on acute, biphasic and chronic autoimmune encephalomyelitis: implication for pathomechanisms of lesion formation.
Park IK; Hiraki K; Kohyama K; Matsumoto Y
J Neuroimmunol; 2008 Feb; 194(1-2):34-43. PubMed ID: 18155779
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
